Over-expression of receptor activator of nuclear factor-κB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty

被引:48
|
作者
Wang, Chen-Ti [1 ,2 ]
Lin, Yu-Tsan [2 ,3 ]
Chiang, Bor-Luen [2 ,3 ]
Lee, Shiou-Shia [2 ,3 ]
Hou, Sheng-Mou [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan
关键词
Osteolysis; Arthroplasty; Receptor activator of nuclear factor-kappa B ligand (RANKL); Cytokine; Chemokine; BONE-RESORPTION; OSTEOCLAST DIFFERENTIATION; INTERFACE TISSUE; SYNOVIAL-FLUID; WEAR DEBRIS; OSTEOPROTEGERIN; REPLACEMENT; MACROPHAGES; PROSTHESES; PARTICLES;
D O I
10.1016/j.biomaterials.2009.09.017
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Loosening of total hip arthroplasty (THA) caused by periprosthetic osteolysis induced by ultra-high molecular weight polyethylene (UHMWPE) particles is a major clinical problem. We investigated whether there are differences between loosened THA patients and primary THA patients in (1) receptor activator of nuclear factor-kappa B ligand (RANKL) expression on periprosthetic bone marrow cells; (2) RANKL levels, osteoprotegerin (OPG)/RANKL ratios, the levels of inflammatory cytokines and chemokines in synovial fluid. We used flow cytometric analysis to detect RANKL expression on periprosthetic bone marrow cells. We used enzyme-linked immunoassay and multiplex microsphere-based immunoassay to measure RANKL, OPG, cytokines, and chemokines in synovial fluid. We found loosened THA patients had higher RANKL expression on osteoblastic stromal cells, higher levels of RANKL, interleukin (IL)-6, IL-8, IL-10, interferon-gamma-inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, monokine induced by interferon-gamma (MIG), and lower OPG/RANKL ratios in synovial fluid than primary THA patients. There was positive correlation between the levels of IL-6, IL-8, IL-10, IP-10, MCP-1, or MIG and RANKL levels in synovial fluid or RANKL expression on osteoblastic stromal cells. These suggest that UHMWPE particles induce over-expression of RANKL, IL-6, IL-8, IP-10, MCP-1, and MIG in human periprosthetic microenvironment. This results in periprosthetic osteolysis and loosening of THA. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [1] Serum levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand as markers of periprosthetic osteolysis
    Granchi, Donatella
    Pellacani, Andrea
    Spina, Mauro
    Cenni, Elisabetta
    Savarino, Lucia Maria
    Baldini, Nicola
    Giunti, Armando
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (07): : 1501 - 1509
  • [2] The Role of Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Ratio in Synovial Fluid as a Potential Marker for Periprosthetic Osteolysis Following Total Ankle Arthroplasty
    Lee, Gun-Woo
    Song, Ji-Eun
    Han, Jeong-Eun
    Kim, Nack-Sung
    Lee, Keun-Bae
    CLINICS IN ORTHOPEDIC SURGERY, 2024, 16 (04) : 661 - 668
  • [3] Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)
    Terpos, Evangelos
    Christoulas, Dimitrios
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (11) : 1265 - 1269
  • [4] Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis
    Atsushi Sasaki
    Kenji Ishikawa
    Naotsugu Haraguchi
    Hiroshi Inoue
    Tetsuya Ishio
    Kohei Shibata
    Masayuki Ohta
    Seigo Kitano
    Masaki Mori
    Annals of Surgical Oncology, 2007, 14 : 1191 - 1199
  • [5] Receptor activator of nuclear Factor-κB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis
    Sasaki, Atsushi
    Ishikawa, Kenji
    Haraguchi, Naotsugu
    Inoue, Hiroshi
    Ishio, Tetsuya
    Shibata, Kohei
    Ohta, Masayuki
    Kitano, Seigo
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1191 - 1199
  • [6] The Effect of Osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) on Aortic Valve Calcified
    Luo, Wei
    Wang, Jing
    Yang, Xia
    Li, Junshan
    Song, Yanqiu
    Cong, Hongliang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (05): : 633 - 642
  • [7] RANK (receptor activator of nuclear factor-κB) and RANKL expression in multiple myeloma
    Roux, S
    Meignin, V
    Quillard, J
    Meduri, G
    Guiochon-Mantel, A
    Fermand, JP
    Milgrom, E
    Mariette, X
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) : 86 - 92
  • [8] Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults
    Jung, K
    Lein, M
    Von Hösslin, K
    Grosse, A
    Roth, S
    Possinger, K
    Lüftner, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 177 - 181
  • [9] Multimerization of the receptor activator of nuclear factor-κB ligand (RANKL) isoforms and regulation of osteoclastogenesis
    Ikeda, T
    Kasai, M
    Suzuki, J
    Kuroyama, H
    Seki, S
    Utsuyama, M
    Hirokawa, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) : 47217 - 47222
  • [10] Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis
    Grimaud, E
    Soubigou, L
    Couillaud, S
    Coipeau, P
    Moreau, A
    Passuti, N
    Gouin, F
    Redini, F
    Heymann, D
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05): : 2021 - 2031